1. Home
  2. BLMN vs EOLS Comparison

BLMN vs EOLS Comparison

Compare BLMN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLMN
  • EOLS
  • Stock Information
  • Founded
  • BLMN 1988
  • EOLS 2012
  • Country
  • BLMN United States
  • EOLS United States
  • Employees
  • BLMN N/A
  • EOLS N/A
  • Industry
  • BLMN Restaurants
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLMN Consumer Discretionary
  • EOLS Health Care
  • Exchange
  • BLMN Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • BLMN 736.6M
  • EOLS 589.3M
  • IPO Year
  • BLMN 2012
  • EOLS 2018
  • Fundamental
  • Price
  • BLMN $6.63
  • EOLS $5.90
  • Analyst Decision
  • BLMN Hold
  • EOLS Strong Buy
  • Analyst Count
  • BLMN 10
  • EOLS 5
  • Target Price
  • BLMN $10.44
  • EOLS $21.25
  • AVG Volume (30 Days)
  • BLMN 2.7M
  • EOLS 2.0M
  • Earning Date
  • BLMN 08-06-2025
  • EOLS 08-05-2025
  • Dividend Yield
  • BLMN 9.05%
  • EOLS N/A
  • EPS Growth
  • BLMN N/A
  • EOLS N/A
  • EPS
  • BLMN N/A
  • EOLS N/A
  • Revenue
  • BLMN $3,933,993,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • BLMN $1.00
  • EOLS $33.42
  • Revenue Next Year
  • BLMN $1.45
  • EOLS $33.18
  • P/E Ratio
  • BLMN N/A
  • EOLS N/A
  • Revenue Growth
  • BLMN N/A
  • EOLS 17.15
  • 52 Week Low
  • BLMN $6.09
  • EOLS $5.85
  • 52 Week High
  • BLMN $18.72
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • BLMN 30.95
  • EOLS 15.64
  • Support Level
  • BLMN $6.18
  • EOLS $5.85
  • Resistance Level
  • BLMN $9.94
  • EOLS $9.35
  • Average True Range (ATR)
  • BLMN 0.59
  • EOLS 0.49
  • MACD
  • BLMN -0.40
  • EOLS -0.37
  • Stochastic Oscillator
  • BLMN 9.96
  • EOLS 1.15

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: